[{"address1": "Modi\u2019in Technology Park", "address2": "2 HaMa\u2019ayan Street", "city": "Hevel Modi'in", "zip": "7177871", "country": "Israel", "phone": "972 8 642 9100", "fax": "972 8 642 9101", "website": "https://www.biolinerx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It also develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.", "fullTimeEmployees": 28, "companyOfficers": [{"maxAge": 1, "name": "Dr. Ella  Sorani Ph.D.", "age": 56, "title": "Chief Development Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 295000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Lacey", "title": "Head of Corporate Communications & Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Raziel  Fried", "title": "Treasurer & Budgetary Control Director", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.43, "open": 2.5, "dayLow": 2.5, "dayHigh": 2.75, "regularMarketPreviousClose": 2.43, "regularMarketOpen": 2.5, "regularMarketDayLow": 2.5, "regularMarketDayHigh": 2.75, "payoutRatio": 0.0, "beta": 0.946, "forwardPE": -12.5, "volume": 24458, "regularMarketVolume": 24458, "averageVolume": 141080, "averageVolume10days": 40180, "averageDailyVolume10Day": 40180, "bid": 2.57, "ask": 0.0, "bidSize": 1, "askSize": 0, "marketCap": 10232750, "fiftyTwoWeekLow": 2.3, "fiftyTwoWeekHigh": 35.6, "priceToSalesTrailing12Months": 0.353585, "fiftyDayAverage": 3.2594, "twoHundredDayAverage": 15.1867, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 5911873024, "profitMargins": -0.31862, "floatShares": 2125883615, "sharesOutstanding": 3721000, "sharesShort": 207530, "sharesShortPriorMonth": 216353, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0583, "heldPercentInsiders": 0.045879997, "heldPercentInstitutions": 0.01372, "shortRatio": 3.87, "shortPercentOfFloat": 0.0634, "impliedSharesOutstanding": 3710940, "bookValue": 0.01, "priceToBook": 275.0, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -9221000, "trailingEps": -6.0, "forwardEps": -0.22, "lastSplitFactor": "1:40", "lastSplitDate": 1738195200, "enterpriseToRevenue": 204.28, "enterpriseToEbitda": -376.576, "52WeekChange": -0.8925781, "SandP52WeekChange": 0.059571505, "quoteType": "EQUITY", "currentPrice": 2.75, "targetHighPrice": 40.0, "targetLowPrice": 26.0, "targetMeanPrice": 33.0, "targetMedianPrice": 33.0, "recommendationMean": 2.5, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 19562000, "totalCashPerShare": 0.009, "ebitda": -15699000, "totalDebt": 15040000, "quickRatio": 1.521, "currentRatio": 1.759, "totalRevenue": 28940000, "debtToEquity": 111.73, "revenuePerShare": 14.4, "returnOnAssets": -0.23281, "returnOnEquity": -0.69113, "grossProfits": 19677000, "freeCashflow": -43885248, "operatingCashflow": -43873000, "revenueGrowth": 1.448, "grossMargins": 0.67991996, "ebitdaMargins": -0.54247004, "operatingMargins": -0.26981002, "financialCurrency": "USD", "symbol": "BLRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "BioLineRx Ltd.", "shortName": "BioLineRx Ltd.", "corporateActions": [], "postMarketTime": 1744404798, "regularMarketTime": 1744401601, "exchange": "NCM", "messageBoardId": "finmb_5015080", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "cryptoTradeable": false, "regularMarketChangePercent": 13.168721, "regularMarketPrice": 2.75, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1311773400000, "postMarketChangePercent": 3.93818, "postMarketPrice": 2.8583, "postMarketChange": 0.1083, "regularMarketChange": 0.31999993, "regularMarketDayRange": "2.5 - 2.75", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 141080, "fiftyTwoWeekLowChange": 0.45000005, "fiftyTwoWeekLowChangePercent": 0.1956522, "fiftyTwoWeekRange": "2.3 - 35.6", "fiftyTwoWeekHighChange": -32.85, "fiftyTwoWeekHighChangePercent": -0.9227528, "fiftyTwoWeekChangePercent": -89.25781, "dividendDate": 1563148800, "earningsTimestamp": 1743418814, "earningsTimestampStart": 1743418814, "earningsTimestampEnd": 1743418814, "earningsCallTimestampStart": 1743424200, "earningsCallTimestampEnd": 1743424200, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -6.0, "epsForward": -0.22, "epsCurrentYear": -3.17, "priceEpsCurrentYear": -0.8675079, "fiftyDayAverageChange": -0.5093999, "fiftyDayAverageChangePercent": -0.1562864, "twoHundredDayAverageChange": -12.4367, "twoHundredDayAverageChangePercent": -0.8189205, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.5 - Buy", "trailingPegRatio": null, "__fetch_time": "2025-04-12"}]